Skip to main content

Elamipretide, a Mitochondria-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with Noncentral Geographic Atrophy: Results of the Phase 1 ReCLAIM Study

Publication ,  Conference
Cousins, SW; Allingham, MJ; Mettu, PS
Published in: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
July 1, 2019

Duke Scholars

Published In

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

EISSN

1552-5783

ISSN

0146-0404

Publication Date

July 1, 2019

Volume

60

Issue

9

Location

Vancouver, CANADA

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Conference Name

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 11 Medical and Health Sciences
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cousins, S. W., Allingham, M. J., & Mettu, P. S. (2019). Elamipretide, a Mitochondria-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with Noncentral Geographic Atrophy: Results of the Phase 1 ReCLAIM Study. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 60). Vancouver, CANADA: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.
Cousins, Scott W., Michael John Allingham, and Priyatham S. Mettu. “Elamipretide, a Mitochondria-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with Noncentral Geographic Atrophy: Results of the Phase 1 ReCLAIM Study.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 60. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2019.
Cousins SW, Allingham MJ, Mettu PS. Elamipretide, a Mitochondria-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with Noncentral Geographic Atrophy: Results of the Phase 1 ReCLAIM Study. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2019.
Cousins, Scott W., et al. “Elamipretide, a Mitochondria-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with Noncentral Geographic Atrophy: Results of the Phase 1 ReCLAIM Study.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 60, no. 9, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2019.
Cousins SW, Allingham MJ, Mettu PS. Elamipretide, a Mitochondria-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with Noncentral Geographic Atrophy: Results of the Phase 1 ReCLAIM Study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2019.

Published In

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

EISSN

1552-5783

ISSN

0146-0404

Publication Date

July 1, 2019

Volume

60

Issue

9

Location

Vancouver, CANADA

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Conference Name

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 11 Medical and Health Sciences
  • 06 Biological Sciences